Morgan M Ballard, MD
Pathology · Boise
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Boise Pathology Group P.A. · 10 clinicians in this group
Looking this up.
Hospitals listed: St Luke'S Magic Valley Rmc · St Luke'S Mccall · St Luke'S Nampa Medical Center · St Luke'S Regional Medical Center · St Luke'S Wood River Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Ballard’s office at (208) 381-2378 to ask if they take your plan before you enroll.
California Medical Board record
Licence A134744 · Cancelled
Licence status: Cancelled · since 2015 · Oregon Health Sciences University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Luke'S MccallMccall, IDCritical Access Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 5 of 5 · 84% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- St Luke'S Nampa Medical CenterNampa, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.25, Oct 2024 – Sep 2025
- St Luke'S Regional Medical CenterBoise, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.459, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.203, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.407, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6.8 to 9.7) · 1,092 cases, Jan 2024 – Dec 2024
- St Luke'S Wood River Medical CenterKetchum, IDCritical Access Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 5 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- St Lukes Magic Valley Medical CenterTwin Falls, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 3 of 5 · 63% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.111, Oct 2024 – Sep 2025
See every measure and the patient survey for St Luke'S Mccall
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 4 the same, 0 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 143 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 51.9 · 26 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 26 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.1 (9 to 16.9) · 374 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 78 cases | No different | Jan 2024 – Dec 2024 |
What patients said (104 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 5 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 73% |
| Yes, staff "did" give patients this information | 97% |
| Yes, staff "did" give patients information about help after discharge | 96% |
| Doctors "always" explained things so they could understand | 82% |
| Doctors "always" listened carefully | 90% |
| Doctors "always" treated them with courtesy and respect | 93% |
| Patients who gave a rating of "9" or "10" (high) | 87% |
| Staff "always" explained new medications | 83% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 75% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 61% |
| Yes, staff "did" give patients information about possible symptoms | 97% |
See every measure and the patient survey for St Luke'S Nampa Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.57 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.6 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,239 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,590 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,581 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.55 to 3.97) · 210 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (0.76 to 9.25) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.89) · 1,236 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.8 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.9) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.4 to 14.7) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.8) · 339 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 388 cases | No different | Jan 2024 – Dec 2024 |
What patients said (496 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for St Luke'S Regional Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.459 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.203 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.407 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6.8 to 9.7) · 1,092 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.61 (0.78 to 2.43) · 2,278 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.6 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.38 (95.48 to 183.27) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 345 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 796 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,937 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,027 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.85 to 5.1) · 2,997 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0 to 2.7) · 1,577 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.25 to 3.8) · 2,793 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (1.86 to 10.74) · 1,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.15 to 7.42) · 1,483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.4 (0.03 to 2.76) · 843 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 7,363 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 124 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.938 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.1 · 607 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.8 · 965 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3 · 373 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -48.3 · 559 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.7 · 546 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 901 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.4) · 1,092 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.2) · 361 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 2,189 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,628 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for St Luke'S Wood River Medical Center
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 10.4 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 48 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 288 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 1.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.9 · 37 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -31.5 · 46 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.5 to 8.6) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7 to 14.7) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.3) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 275 cases | No different | Jan 2024 – Dec 2024 |
What patients said (205 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 79% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 87% |
| Staff "always" explained | 67% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 95% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 86% |
| Doctors "always" treated them with courtesy and respect | 93% |
| Patients who gave a rating of "9" or "10" (high) | 84% |
| Staff "always" explained new medications | 84% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 66% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for St Lukes Magic Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 5 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.111 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.68 (0.67 to 2.7) · 653 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.67 to 1.39) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 172.64 (117.31 to 227.96) · 46 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.4 · 62 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 168 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15.1 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 325 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.7 · 163 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 2,313 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.4 (0.19 to 0.62) · 3,648 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,651 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 761 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.97 (0.31 to 3.63) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.83 (1.24 to 4.43) · 727 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.69 (5.06 to 20.32) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.03 (2.47 to 9.59) · 226 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.49 to 3.46) · 159 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,807 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 29 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.926 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.527 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.57 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 232 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.2 · 172 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -41 · 275 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -20.6 · 328 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 493 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 124 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.9 (8.5 to 14.2) · 1,953 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 623 cases | No different | Jan 2024 – Dec 2024 |
What patients said (718 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 63% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$73,267
Medicare paid this office $73,267 for 812 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, moderately high complexity | 18 | $11,160 | $124 |
| Pathology examination of tissue using a microscope, intermediate complexity | 226 | $9,834 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 47 | $6,940 | $61 |
| Special stained specimen slides to examine tissue, each additional procedure | 93 | $6,789 | $21 |
| Microscopic genetic analysis of tumor, manual | 59 | $5,446 | $31 |
See all 23 services
| Pathology examination of tissue using a microscope, moderately high complexity | 18 | $11,160 | $124 |
| Pathology examination of tissue using a microscope, intermediate complexity | 226 | $9,834 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 47 | $6,940 | $61 |
| Special stained specimen slides to examine tissue, each additional procedure | 93 | $6,789 | $21 |
| Microscopic genetic analysis of tumor, manual | 59 | $5,446 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 125 | $4,292 | $26 |
| Protein measurement, serum | 185 | $2,477 | $12 |
| Pathology examination of tissue using a microscope, intermediate complexity | 43 | $2,417 | $40 |
| Special stained specimen slides to examine tissue, initial procedure | 21 | $2,182 | $59 |
| Pathology examination of specimen during surgery, first tissue block | 24 | $1,924 | $46 |
| Immunologic analysis technique on serum (immunofixation) | 115 | $1,603 | $13 |
| Special stained specimen slides to examine tissue, each additional procedure | 16 | $1,541 | $44 |
| Evaluation of fine needle aspirate with interpretation and report | 22 | $1,431 | $51 |
| Cell examination of specimen, selective cellular enhancement technique | 60 | $1,235 | $20 |
| Protein measurement, serum | 85 | $1,229 | $12 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 24 | $981 | $32 |
| Immunologic analysis technique on serum (immunofixation) | 59 | $881 | $12 |
| Blood smear interpretation by physician with written report | 34 | $563 | $17 |
| Examination of archival tissue for genetic analysis | 38 | $554 | $14 |
| Protein measurement, body fluid | 38 | $507 | $13 |
| Evaluation of fine needle aspirate | 12 | $471 | $26 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 30 | $414 | $13 |
| Pathology examination of tissue using a microscope, moderately low complexity | 36 | $311 | $8 |
Who their Medicare patients are
812 Original Medicare patients in 2024. Average age 73 · Under 65 7% · 85 and older 10% · Women 58% · Also on Medicaid 10% · Health risk score 1.48. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 70% · Cancer 30% · Chronic kidney disease 29% · Diabetes 26% · Depression 25% · Coronary heart disease 19% · Atrial fibrillation 18% · COPD 14% · Heart failure 13% · Dementia 6% · Stroke 6%.
The office billed $193,367, Medicare allowed $93,015 and paid $73,267; for 2,416 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 812 | 2,416 | 73 | 1.48 | $193,367 | $73,267 |
| 2023 | 806 | 2,455 | 74 | 1.49 | $179,112 | $67,102 |
| 2022 | 688 | 2,033 | 73 | 1.43 | $152,547 | $58,886 |
| 2021 | 474 | 1,575 | 72 | 1.36 | $127,072 | $50,056 |
| 2020 | 507 | 1,828 | 72 | 1.48 | $151,887 | $58,580 |
| 2019 | 329 | 950 | 71 | 1.42 | $94,723 | $30,954 |
| 2018 | 158 | 454 | 71 | 1.31 | $43,525 | $15,426 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 25 services
| Pathology examination of tissue using a microscope, intermediate complexity | 283 | $12,787 | $27 |
| Pathology examination of tissue using a microscope, moderately high complexity | 89 | $12,183 | $60 |
| Special stained specimen slides to examine tissue, each additional procedure | 117 | $8,538 | $21 |
| Special stained specimen slides to examine tissue, initial procedure | 163 | $5,490 | $26 |
| Microscopic genetic analysis of tumor, manual | 61 | $5,272 | $29 |
| Protein measurement, serum | 150 | $1,992 | $12 |
| Pathology examination of tissue using a microscope, intermediate complexity | 39 | $1,755 | $42 |
| Evaluation of fine needle aspirate with interpretation and report | 21 | $1,624 | $52 |
| Pathology examination of tissue using a microscope, high complexity | 14 | $1,515 | $108 |
| Cell examination of specimen, selective cellular enhancement technique | 63 | $1,349 | $20 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 30 | $1,226 | $32 |
| Pathology examination of specimen during surgery, first tissue block | 17 | $1,111 | $46 |
| Immunologic analysis technique on serum (immunofixation) | 72 | $1,006 | $12 |
| Protein measurement, serum | 70 | $955 | $12 |
| Special stained specimen slides to examine tissue, initial procedure | 15 | $893 | $47 |
| Immunologic analysis technique on serum (immunofixation) | 45 | $617 | $12 |
| Evaluation of fine needle aspirate | 14 | $611 | $27 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $497 | $20 |
| Blood smear interpretation by physician with written report | 25 | $446 | $18 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 32 | $442 | $12 |
| Special stained specimen slides to examine tissue including interpretation and report | 18 | $296 | $9 |
| Pathology examination of tissue using a microscope, moderately low complexity | 32 | $286 | $8 |
| Examination of archival tissue for genetic analysis | 16 | $228 | $14 |
| Protein measurement, body fluid | 16 | $205 | $12 |
| Preparation of tissue for examination by removing any calcium present | 21 | $193 | $9 |
2022: 19 services
| Pathology examination of tissue using a microscope, moderately high complexity | 92 | $12,377 | $63 |
| Pathology examination of tissue using a microscope, intermediate complexity | 265 | $11,967 | $28 |
| Special stained specimen slides to examine tissue, each additional procedure | 93 | $7,420 | $21 |
| Special stained specimen slides to examine tissue, initial procedure | 145 | $4,735 | $26 |
| Microscopic genetic analysis of tumor, manual | 54 | $4,683 | $32 |
| Pathology examination of specimen during surgery, first tissue block | 26 | $2,137 | $47 |
| Pathology examination of tissue using a microscope, intermediate complexity | 42 | $1,931 | $38 |
| Evaluation of fine needle aspirate with interpretation and report | 18 | $1,770 | $54 |
| Cell examination of specimen, selective cellular enhancement technique | 76 | $1,641 | $20 |
| Protein measurement, serum | 97 | $1,358 | $13 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 31 | $1,242 | $34 |
| Immunologic analysis technique on serum (immunofixation) | 48 | $666 | $14 |
| Evaluation of fine needle aspirate | 11 | $649 | $27 |
| Special stained specimen slides to identify organisms including interpretation and report | 13 | $606 | $20 |
| Protein measurement, serum | 39 | $580 | $14 |
| Special stained specimen slides to examine tissue, initial procedure | 12 | $534 | $44 |
| Pathology examination of tissue using a microscope, moderately low complexity | 36 | $330 | $9 |
| Immunologic analysis technique on serum (immunofixation) | 19 | $277 | $14 |
| Immunologic analysis technique on body fluid, other fluids with concentration | 16 | $222 | $12 |
2021: 18 services
| Pathology examination of tissue using a microscope, intermediate complexity | 242 | $11,298 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 85 | $11,278 | $64 |
| Special stained specimen slides to examine tissue, each additional procedure | 89 | $6,085 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 122 | $4,418 | $27 |
| Microscopic genetic analysis of tumor, manual | 37 | $2,925 | $33 |
| Pathology examination of tissue using a microscope, intermediate complexity | 46 | $2,154 | $40 |
| Pathology examination of tissue using a microscope, high complexity | 12 | $1,591 | $114 |
| Cell examination of specimen, selective cellular enhancement technique | 54 | $1,306 | $21 |
| Evaluation of fine needle aspirate with interpretation and report | 15 | $1,044 | $55 |
| Pathology examination of specimen during surgery, first tissue block | 17 | $979 | $44 |
| Special stained specimen slides to identify organisms including interpretation and report | 16 | $835 | $21 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 15 | $516 | $34 |
| Special stained specimen slides to examine tissue including interpretation and report | 18 | $488 | $9 |
| Evaluation of fine needle aspirate | 11 | $390 | $28 |
| Pathology examination of tissue using a microscope, moderately low complexity | 38 | $379 | $9 |
| Examination of archival tissue for genetic analysis | 15 | $228 | $15 |
| Pap test | 11 | $164 | $15 |
| Preparation of tissue for examination by removing any calcium present | 15 | $164 | $10 |
2020: 16 services
| Pathology examination of tissue using a microscope, moderately high complexity | 94 | $15,622 | $66 |
| Pathology examination of tissue using a microscope, intermediate complexity | 278 | $12,768 | $28 |
| Special stained specimen slides to examine tissue, each additional procedure | 98 | $7,065 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 136 | $5,220 | $27 |
| Microscopic genetic analysis of tumor, manual | 52 | $4,127 | $31 |
| Cell examination of specimen, selective cellular enhancement technique | 83 | $1,879 | $22 |
| Pathology examination of specimen during surgery, first tissue block | 21 | $1,660 | $49 |
| Evaluation of fine needle aspirate with interpretation and report | 19 | $1,644 | $57 |
| Pathology examination of tissue using a microscope, intermediate complexity | 45 | $1,628 | $30 |
| Evaluation of fine needle aspirate | 18 | $806 | $29 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $531 | $21 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 13 | $520 | $31 |
| Special stained specimen slides to examine tissue, initial procedure | 11 | $390 | $32 |
| Special stained specimen slides to examine tissue including interpretation and report | 24 | $384 | $9 |
| Pathology examination of tissue using a microscope, moderately low complexity | 32 | $298 | $9 |
| Preparation of tissue for examination by removing any calcium present | 22 | $255 | $10 |
2019: 12 services
| Pathology examination of tissue using a microscope, intermediate complexity | 178 | $7,856 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 49 | $6,146 | $65 |
| Microscopic genetic analysis of tumor, manual | 32 | $3,044 | $33 |
| Special stained specimen slides to examine tissue, each additional procedure | 40 | $2,377 | $21 |
| Special stained specimen slides to examine tissue, initial procedure | 67 | $2,337 | $27 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $1,184 | $49 |
| Pathology examination of tissue using a microscope, intermediate complexity | 26 | $1,061 | $37 |
| Cell examination of specimen, selective cellular enhancement technique | 46 | $1,026 | $21 |
| Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure | 16 | $680 | $34 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $525 | $21 |
| Pathology examination of tissue using a microscope, moderately low complexity | 23 | $214 | $9 |
| Preparation of tissue for examination by removing any calcium present | 11 | $117 | $10 |
2018: 7 services
| Pathology examination of tissue using a microscope, intermediate complexity | 78 | $3,671 | $30 |
| Pathology examination of tissue using a microscope, moderately high complexity | 22 | $3,039 | $66 |
| Special stained specimen slides to examine tissue, each additional procedure | 20 | $1,761 | $23 |
| Special stained specimen slides to examine tissue, initial procedure | 28 | $1,099 | $28 |
| Pathology examination of tissue using a microscope, intermediate complexity | 22 | $892 | $37 |
| Cell examination of specimen, selective cellular enhancement technique | 20 | $446 | $22 |
| Pathology examination of tissue using a microscope, moderately low complexity | 12 | $110 | $9 |
Medicaid work
$7,113 in 2024
Medicaid paid $7,113 for 127 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 112 | $4,524 |
| TISSUE EXAM BY PATHOLOGIST | 15 | $2,590 |
| 2024 | 127 | 2 | 27 | $7,113 |
| 2023 | 365 | 4 | 40 | $16,630 |
| 2022 | 276 | 3 | 28 | $12,775 |
| 2021 | 228 | 2 | 30 | $13,394 |
| 2020 | 223 | 3 | 25 | $10,890 |
| 2019 | 78 | 1 | 21 | $2,826 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 247 | $11,437 |
| TISSUE EXAM BY PATHOLOGIST | 45 | $3,192 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 47 | $1,780 |
| TISSUE EXAM BY PATHOLOGIST | 26 | $222 |
2022
| TISSUE EXAM BY PATHOLOGIST | 250 | $11,712 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 13 | $890 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $173 |
2021
| TISSUE EXAM BY PATHOLOGIST | 214 | $12,288 |
| TISSUE EXAM BY PATHOLOGIST | 14 | $1,106 |
2020
| TISSUE EXAM BY PATHOLOGIST | 185 | $9,047 |
| TISSUE EXAM BY PATHOLOGIST | 24 | $1,642 |
| TISSUE EXAM BY PATHOLOGIST | 14 | $200 |
2019
| TISSUE EXAM BY PATHOLOGIST | 78 | $2,826 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 90.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1861836504
- Licence
- CA A134744California A134744: Cancelled
- Trained
- Oregon Health Sciences University School of Medicine, 2013
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Student in a training program (390200000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2013-04-24
- NPI last updated
- 2018-06-19
This is when the NPI record was last certified, not a medical board exam.